176 related articles for article (PubMed ID: 16260277)
41. Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma.
Abdul-Al HM; Wang G; Makhlouf HR; Goodman ZD
Int J Surg Pathol; 2010 Oct; 18(5):313-8. PubMed ID: 20444731
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining.
Weinbreck N; Marie B; Bressenot A; Montagne K; Joud A; Baumann C; Klein O; Vignaud JM
Am J Surg Pathol; 2008 Jul; 32(7):1051-9. PubMed ID: 18496143
[TBL] [Abstract][Full Text] [Related]
43. Hepatocellular carcinoma presenting as a precocious cutaneous metastasis.
Royer MC; Rush WL; Lupton GP
Am J Dermatopathol; 2008 Feb; 30(1):77-80. PubMed ID: 18212552
[TBL] [Abstract][Full Text] [Related]
44. [Three deceptive cases of intrahepatic metastases of colorectal origin with endobiliary growth, simulating cholangiocarcinoma. Importance of immunostaining of cytokeratin 7 and 20].
Rullier A; Le Bail B; Rullier E; Lamouliatte H; Saric J; Bioulac-Sage P
Ann Pathol; 1999 Mar; 19(1):33-6. PubMed ID: 10320910
[TBL] [Abstract][Full Text] [Related]
45. CD10 immunostaining of bile canaliculi in liver biopsies: change of staining pattern with the development of cirrhosis.
Shousha S; Gadir F; Peston D; Bansi D; Thillainaygam AV; Murray-Lyon IM
Histopathology; 2004 Oct; 45(4):335-42. PubMed ID: 15469471
[TBL] [Abstract][Full Text] [Related]
46. Histologic characteristics and prognostic significance in small hepatocellular carcinoma with biliary differentiation: subdivision and comparison with ordinary hepatocellular carcinoma.
Aishima S; Nishihara Y; Kuroda Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Am J Surg Pathol; 2007 May; 31(5):783-91. PubMed ID: 17460464
[TBL] [Abstract][Full Text] [Related]
47. Annexin A2 as a differential diagnostic marker of hepatocellular tumors.
Longerich T; Haller MT; Mogler C; Aulmann S; Lohmann V; Schirmacher P; Brand K
Pathol Res Pract; 2011 Jan; 207(1):8-14. PubMed ID: 20971570
[TBL] [Abstract][Full Text] [Related]
48. A case series and immunophenotypic analysis of CK20-/CK7+ primary neuroendocrine carcinoma of the skin.
Calder KB; Coplowitz S; Schlauder S; Morgan MB
J Cutan Pathol; 2007 Dec; 34(12):918-23. PubMed ID: 18001414
[TBL] [Abstract][Full Text] [Related]
49. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.
Wang XY; Degos F; Dubois S; Tessiore S; Allegretta M; Guttmann RD; Jothy S; Belghiti J; Bedossa P; Paradis V
Hum Pathol; 2006 Nov; 37(11):1435-41. PubMed ID: 16949914
[TBL] [Abstract][Full Text] [Related]
50. Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma.
Itoyama M; Hata M; Yamanegi K; Yamada N; Ohyama H; Hirano H; Terada N; Nakasho K
Med Mol Morphol; 2012 Dec; 45(1):7-13. PubMed ID: 22431178
[TBL] [Abstract][Full Text] [Related]
51. Intrahepatic cholangiocarcinoma arising in cirrhotic liver frequently expressed p63-positive basal/stem-cell phenotype.
Nomoto K; Tsuneyama K; Cheng C; Takahashi H; Hori R; Murai Y; Takano Y
Pathol Res Pract; 2006; 202(2):71-6. PubMed ID: 16377099
[TBL] [Abstract][Full Text] [Related]
52. Carcinoma, a fibrolamellar variant--immunohistochemical analysis of 4 cases.
Górnicka B; Ziarkiewicz-Wróblewska B; Wróblewski T; Wilczynski GM; Koperski L; Krawczyk M; Wasiutynski A
Hepatogastroenterology; 2005; 52(62):519-23. PubMed ID: 15816470
[TBL] [Abstract][Full Text] [Related]
53. Immunocytochemical evaluation of liver fine-needle aspirations.
Bedrossian CW; Davila RM; Merenda G
Arch Pathol Lab Med; 1989 Nov; 113(11):1225-30. PubMed ID: 2479356
[TBL] [Abstract][Full Text] [Related]
54. Ectopeptidases are differentially expressed in hepatocellular carcinomas.
Röcken C; Carl-McGrath S; Gräntzdörffer I; Mantke R; Roessner A; Lendeckel U
Int J Oncol; 2004 Mar; 24(3):487-95. PubMed ID: 14767532
[TBL] [Abstract][Full Text] [Related]
55. Human pancreatic mucinous cystadenoma is characterized by distinct mucin, cytokeratin and CD10 expression compared with intraductal papillary-mucinous adenoma.
Handra-Luca A; Fléjou JF; Rufat P; Corcos O; Belghiti J; Ruszniewski P; Degott C; Bedossa P; Couvelard A
Histopathology; 2006 Jun; 48(7):813-21. PubMed ID: 16722930
[TBL] [Abstract][Full Text] [Related]
56. Expression and localization of aquaporin-1 in human cirrhotic liver.
Xian ZH; Cong WM; Wang YH; Wang B; Wu MC
Pathol Res Pract; 2009; 205(11):774-80. PubMed ID: 19619954
[TBL] [Abstract][Full Text] [Related]
57. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
Nassar A; Cohen C; Siddiqui MT
Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109
[TBL] [Abstract][Full Text] [Related]
58. Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma.
Lagana SM; Salomao M; Remotti HE; Knisely AS; Moreira RK
Histopathology; 2015 Mar; 66(4):598-602. PubMed ID: 25378077
[TBL] [Abstract][Full Text] [Related]
59. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis.
Rullier A; Le Bail B; Fawaz R; Blanc JF; Saric J; Bioulac-Sage P
Am J Surg Pathol; 2000 Jun; 24(6):870-6. PubMed ID: 10843291
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
